title: Acute humoral rejection in a lung recipient: reversion with bortezomib.
authors.forename: Jorge
authors.initials: J
authors.lastname: Neumann
authors.forename: Heloisa
authors.initials: H
authors.lastname: Tarrasconi
authors.forename: Andrea
authors.initials: A
authors.lastname: Bortolotto
authors.forename: Tiago
authors.initials: T
authors.lastname: Machuca
authors.forename: Raquel
authors.initials: R
authors.lastname: Canabarro
authors.forename: Heloisa
authors.initials: H
authors.lastname: Sporleder
authors.forename: Sandra
authors.initials: S
authors.lastname: Fernandes
authors.forename: Sadi
authors.initials: S
authors.lastname: Schio
authors.forename: Clarisse
authors.initials: C
authors.lastname: Costa
authors.forename: Spencer
authors.initials: S
authors.lastname: Camargo
authors.forename: Leticia
authors.initials: L
authors.lastname: Sanchez
authors.forename: Jose
authors.initials: J
authors.lastname: Camargo
authors.forename: Fabiola
authors.initials: F
authors.lastname: Perin
authors.forename: Jose
authors.initials: J
authors.lastname: Felicetti
authors.forename: Tatiana
authors.initials: T
authors.lastname: Michelon
mesh_terms: D000328:Adult; D001706:Biopsy; D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D002102:Cadaver; D005260:Female; D006084:Graft Rejection / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology; D006801:Humans; D056724:Immunity, Humoral; D016040:Lung Transplantation / Q000276:immunology* / Q000473:pathology; D008875:Middle Aged; D011183:Postoperative Complications / Q000473:pathology; D011480:Protease Inhibitors / Q000627:therapeutic use*; D011719:Pyrazines / Q000627:therapeutic use*; D013601:T-Lymphocytes / Q000276:immunology; D014019:Tissue Donors; D016896:Treatment Outcome
chemical_list: D001897:Boronic Acids; D011480:Protease Inhibitors; D011719:Pyrazines; D000069286:Bortezomib